S. 4430 · 117th Congress
Interagency Patent Coordination and Improvement Act of 2022
- Stage
- Reported from committee
- Sponsor
- Richard Durbin
- Introduced
- 2022-06-16
- Latest action
- 2022-08-02 · Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Summary
Interagency Patent Coordination and Improvement Act of 2022
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.